Company / Net Income
GYRE THERAPEUTICS, INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$9.9M
FY2025
5-year range
-$87.9M / $17.9M
FY2021-FY2025
Trend
-44.8%
vs FY2024
Sector context
#57 of 216
Health Care
What the data says
At $10M, GYRE THERAPEUTICS, INC.'s net income ranks #57 of 216 in the Health Care sector. Improved from $4M to $10M over the past 2 years.
Based on SEC 10-K filings.
$10M in FY2025 with a 3-year CAGR of +31.8%.
Improved from $4M to $10M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +31.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#57 of 216 in Health CareTop 26% of 216This company $9.9M Sector average $454.1M
▼
-97.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +31.8%, indicating consistent growth.
- In FY2025, net income decreased 44.8% year-over-year.
- Ranks #57 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.9M | -44.8% |
| FY2024 | $17.9M | +314.9% |
| FY2023 | $4.3M | +0.0% |
| FY2022 | $4.3M | +104.9% |
| FY2021 | -$87.9M | -59.4% |
| FY2020 | -$55.2M | +0.0% |
| FY2019 | -$55.2M | -155.9% |
| FY2018 | -$21.6M | +0.0% |
| FY2017 | -$21.6M | -27.2% |
| FY2016 | -$16.9M | -14.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026